| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SELECT SECTOR SPDR TR SBI HEALTHCARE | 500,000 | 36,016,000 | 11.85% | Put | |
| 2 | CELGENE CORP | 200,000 | 23,952,000 | 7.88% | ||
| 3 | CIGNA CORPORATION | 135,000 | 19,755,000 | 6.50% | ||
| 4 | AMGEN INC | 100,000 | 16,233,000 | 5.34% | ||
| 5 | ULTRAGENYX PHARMACEUTICAL INC COM | 115,000 | 12,901,000 | 4.24% | ||
| 6 | BAXTER INTL INC | 325,000 | 12,399,000 | 4.08% | ||
| 7 | MYLAN N V | 225,000 | 12,166,000 | 4.00% | ||
| 8 | TEVA PHARMACEUTICAL INDS LTD | 150,000 | 9,846,000 | 3.24% | ||
| 9 | GILEAD SCIENCES INC | 90,000 | 9,107,000 | 3.00% | ||
| 10 | ONCOMED PHARMACEUTICALS INC | 400,000 | 9,016,000 | 2.97% | ||
| 11 | ACCELERON PHARMA | 150,000 | 7,314,000 | 2.41% | ||
| 12 | BIOGEN INC | 20,000 | 6,127,000 | 2.02% | ||
| 13 | AETNA INC NEW | 50,000 | 5,406,000 | 1.78% | ||
| 14 | MERCK & CO INC | 100,000 | 5,282,000 | 1.74% | ||
| 15 | EXPRESS SCRIPTS HLDG CO | 60,000 | 5,245,000 | 1.73% | ||
| 16 | ENDO INTL | 75,000 | 4,592,000 | 1.51% | ||
| 17 | ADAPTIMMUNE THERAPEUTICS PLC | 353,161 | 4,259,000 | 1.40% | ||
| 18 | ALLSCRIPTS HEALTHCARE | 275,000 | 4,230,000 | 1.39% | ||
| 19 | GW PHARMACEUTICALS PLC | 60,687 | 4,214,000 | 1.39% | ||
| 20 | SAREPTA THERAPEUTICS INC | 100,000 | 3,858,000 | 1.27% | ||
| 21 | PACIRA BIOSCIENCES INC | 50,000 | 3,840,000 | 1.26% | ||
| 22 | ACCELERATE DIAGNOSTICS INC | 175,000 | 3,761,000 | 1.24% | ||
| 23 | CYTOKINETICS INC | 350,000 | 3,661,000 | 1.20% | ||
| 24 | GLOBAL BLOOD THERAPEUTICS IN COM | 110,000 | 3,556,000 | 1.17% | ||
| 25 | Heartware International, Inc. | 70,000 | 3,528,000 | 1.16% | ||
| 26 | ENVISION HEALTHCARE HLDGS INC | 125,000 | 3,246,000 | 1.07% | ||
| 27 | APPLIED GENETIC TECHNOL CORP | 150,000 | 3,060,000 | 1.01% | ||
| 28 | LA JOLLA PHARMACEUTICAL CO | 110,000 | 2,970,000 | 0.98% | ||
| 29 | SAGE THERAPEUTICS | 50,000 | 2,915,000 | 0.96% | ||
| 30 | HEALTHWAYS INC | 225,000 | 2,896,000 | 0.95% | ||
| 31 | BROOKDALE SR LIVING INC | 150,000 | 2,769,000 | 0.91% | ||
| 32 | NUVASIVE INC COM | 50,000 | 2,706,000 | 0.89% | ||
| 33 | DERMIRA INC | 75,000 | 2,596,000 | 0.85% | ||
| 34 | ZIMMER BIOMET HLDGS INC | 25,000 | 2,565,000 | 0.84% | Call | |
| 35 | NOVADAQ TECHNOLOGIES INC | 200,000 | 2,548,000 | 0.84% | ||
| 36 | VALEANT PHARMACEUTICALS INTL | 25,000 | 2,541,000 | 0.84% | ||
| 37 | MEDIVATION INC | 50,000 | 2,417,000 | 0.80% | ||
| 38 | ALNYLAM PHARMACEUTICALS INC | 25,000 | 2,354,000 | 0.77% | ||
| 39 | STRYKER CORP | 25,000 | 2,324,000 | 0.76% | Call | |
| 40 | TENET HEALTHCARE CORP | 75,000 | 2,273,000 | 0.75% | ||
| 41 | ZOGENIX INC | 150,000 | 2,211,000 | 0.73% | ||
| 42 | RADIUS HEALTH | 35,000 | 2,154,000 | 0.71% | ||
| 43 | IGNYTA INC COM | 160,000 | 2,144,000 | 0.71% | ||
| 44 | ZELTIQ AESTHETICS INCORPORATED | 75,000 | 2,140,000 | 0.70% | ||
| 45 | IMPAX LABORATORIES INC | 50,000 | 2,138,000 | 0.70% | ||
| 46 | SUPERNUS PHARMACEUTICALS INC COM | 150,000 | 2,016,000 | 0.66% | ||
| 47 | PUMA BIOTECHNOLOGY | 25,000 | 1,960,000 | 0.64% | ||
| 48 | SANGAMO BIOSCIENCES INCORPORATED | 200,000 | 1,826,000 | 0.60% | ||
| 49 | DEPOMED INC | 100,000 | 1,813,000 | 0.60% | ||
| 50 | COHERUS BIOSCIENCES INC COM | 75,000 | 1,722,000 | 0.57% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001597549-16-000016, filed 2016.02.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
